申请人:Morioka Masahiko
公开号:US20090292121A1
公开(公告)日:2009-11-26
A therapeutic drug for cancer containing a substance selected from the group consisting of a novel cyanopyridine derivative, a pharmaceutically acceptable salt, a hydrate, a water adduct and a solvate as an active ingredient can be provided.
可以提供一种治疗癌症的药物,其中包含从新型氰基吡啶衍生物、药学上可接受的盐、水合物、水加合物和溶剂加合物中选择的物质作为活性成分。